HCV entry inhibitors (Microbiotix)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameHCV entry inhibitors (Microbiotix)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEnvelope glycoprotein modulators

TargetsEnvelope glycoprotein

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMicrobiotix Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMicrobiotix Inc

Active IndicationsN/A

Inactive IndicationsHepatitis C

ATC CodeN/A